Aging: Clinical Trials

5 trials of Aging, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated. 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 15Completed 4, Terminated 1

Follow Aging: new trials by email Literature Review of Aging trials Research Report on Aging

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Immunogenicity First-in-human Dose-ranging Study of Self-Amplifying RNA Seasonal Influenza Vaccine in Adults
ARCT-2138, Licensed Quadrivalent Vaccine for younger adults, Licensed Quadrivalent Vaccine for older adults - Influenza, Human
Phase 1CompletedArcturus Therapeutics, Inc.1392024-01-222025-10-03
A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)
Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Aged 6 Years and Older) (Tdcp), 23-Valent Pneumococcal Polysaccharide Vaccine(PPV23), Diphtheria and Tetanus Combined Vaccine, Adsorbed (DT) - Diphtheria, Tetanus
Phase 1CompletedCanSino Biologics Inc.1802023-12-062026-08-07
Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable Schizophrenia
ITI-214 Dose A, ITI-214 Dose B, ITI-214 Dose C - Schizophrenia
Phase 1TerminatedTakeda762013-07-012015-02-19
Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in INDIA (PROVIDE)
IPV vaccination - Poliomyelitis, Tropical Enteropathy
Phase 1CompletedInternational Vaccine Institute3722012-03-012017-08-31
Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia
Dasatinib, Mitoxantrone, Cytarabine - Leukemia, Acute Lymphoblastic Leukemia
Phase 1CompletedMemorial Sloan Kettering Cancer Center72009-07-012014-04-10

Conditions studied

Diphtheria (1)  ·  Influenza, Human (1)  ·  Leukemia (1)  ·  Poliomyelitis (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Schizophrenia (1)  ·  Sprue, Tropical (1)  ·  Tetanus (1)  ·  Whooping Cough (1)

Sponsors

Arcturus Therapeutics, Inc. (1)  ·  CanSino Biologics Inc. (1)  ·  International Vaccine Institute (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Takeda (1)

Countries

United States (2)  ·  Australia (1)  ·  China (1)  ·  India (1)

Top investigators

Ayan Dey, Ph.D (1)  ·  Beth Kirkpatrick, M.D. (1)  ·  Ranjan K Nandy, M.D. (1)  ·  Renier Brentjens, MD, PhD (1)  ·  Suman Kanungo, M.D. (1)  ·  William Petri, M.D (1)

Results publications

PMID 28194449, PMID 40977696